{"created":"2024-03-30T02:40:08.531513+00:00","id":2000271,"links":{},"metadata":{"_buckets":{"deposit":"aaceef10-9b55-438d-9b0e-991678a6c8d3"},"_deposit":{"created_by":14,"id":"2000271","owner":"14","owners":[14],"pid":{"revision_id":0,"type":"depid","value":"2000271"},"status":"published"},"_oai":{"id":"oai:dmu.repo.nii.ac.jp:02000271","sets":["8:1710732483666"]},"author_link":[],"control_number":"2000271","item_10006_date_granted_11":{"attribute_name":"学位授与年月日","attribute_value_mlt":[{"subitem_dategranted":"2023-03-03"}]},"item_10006_degree_grantor_9":{"attribute_name":"学位授与機関","attribute_value_mlt":[{"subitem_degreegrantor":[{"subitem_degreegrantor_language":"ja","subitem_degreegrantor_name":"獨協医科大学"}],"subitem_degreegrantor_identifier":[{"subitem_degreegrantor_identifier_name":"32203","subitem_degreegrantor_identifier_scheme":"kakenhi"}]}]},"item_10006_degree_name_8":{"attribute_name":"学位名","attribute_value_mlt":[{"subitem_degreename":"博士（医学）","subitem_degreename_language":"ja"}]},"item_10006_description_10":{"attribute_name":"学位授与年度","attribute_value_mlt":[{"subitem_description":"令和4年度","subitem_description_language":"ja","subitem_description_type":"Other"}]},"item_10006_dissertation_number_12":{"attribute_name":"学位授与番号","attribute_value_mlt":[{"subitem_dissertationnumber":"甲第860号"}]},"item_10006_relation_15":{"attribute_name":"関連サイト","attribute_value_mlt":[{"subitem_relation_type":"isVersionOf","subitem_relation_type_id":{"subitem_relation_type_id_text":"https://doi.org/10.1097/FTD.0000000000000778","subitem_relation_type_select":"DOI"}}]},"item_10006_rights_13":{"attribute_name":"権利","attribute_value_mlt":[{"subitem_rights":"This is a pre-copyedited, author-produced version of an article accepted for publication in Therapeutic Drug Monitoring . The published version of record Yokoyama, Saaya MD*; Yasui-Furukori, Norio MD, PhD*,†; Nakagami, Taku MD, PhD‡; Miyazaki, Kensuke MD§; Ishioka, Masamichi MD, PhD¶; Tarakita, Natsumi MD║; Kubo, Kazutoshi MD, PhD*,*; Sugawara, Norio MD, PhD*; Shimoda, Kazutaka MD, PhD*. Association Between the Serum Carnitine Level and Ammonia and Valproic Acid Levels in Patients with Bipolar Disorder. Therapeutic Drug Monitoring 42(5):p 766-770, October 2020.  is available online at: https://doi.org/10.1097/FTD.0000000000000778.","subitem_rights_language":"en"}]},"item_access_right":{"attribute_name":"アクセス権","attribute_value_mlt":[{"subitem_access_right":"open access","subitem_access_right_uri":"http://purl.org/coar/access_right/c_abf2"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"横山, 沙安也","creatorNameLang":"ja"}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_access","date":[{"dateType":"Available","dateValue":"2024-03-30"}],"filename":"32203-K860-S.pdf","filesize":[{"value":"755 KB"}],"format":"application/pdf","mimetype":"application/pdf","url":{"label":"32203-K860-主論文要旨および審査結果の要旨","url":"https://dmu.repo.nii.ac.jp/record/2000271/files/32203-K860-S.pdf"},"version_id":"3aa111eb-ca9a-484e-8dbe-fadbcd67f29b"},{"accessrole":"open_access","date":[{"dateType":"Available","dateValue":"2024-03-30"}],"filename":"32203-K860-A.pdf","filesize":[{"value":"795 KB"}],"format":"application/pdf","mimetype":"application/pdf","url":{"label":"32203-K860-本文","objectType":"fulltext","url":"https://dmu.repo.nii.ac.jp/record/2000271/files/32203-K860-A.pdf"},"version_id":"24d554d9-5502-42ea-897e-67a0c0dc1837"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"eng"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"doctoral thesis","resourceuri":"http://purl.org/coar/resource_type/c_db06"}]},"item_title":"Association between the serum carnitine level and ammonia and valproic acid levels in patients with bipolar disorder","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"Association between the serum carnitine level and ammonia and valproic acid levels in patients with bipolar disorder","subitem_title_language":"en"}]},"item_type_id":"10006","owner":"14","path":["1710732483666"],"pubdate":{"attribute_name":"PubDate","attribute_value":"2024-03-30"},"publish_date":"2024-03-30","publish_status":"0","recid":"2000271","relation_version_is_last":true,"title":["Association between the serum carnitine level and ammonia and valproic acid levels in patients with bipolar disorder"],"weko_creator_id":"14","weko_shared_id":-1},"updated":"2024-05-01T06:32:47.633384+00:00"}